Evgen Pharma Share Price (EVG)
| Bid price | 8.30 | Open price | 8.10 |
|---|---|---|---|
| Ask price | 8.30 | Prev close | 8.30 |
| High price | 0.00 | Spread | 0.00% |
| Low price | 0.00 | Volume | 0 |
Register now for FREE live Evgen Pharma share prices, Evgen Pharma stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Evgen Pharma Level 2 Data, indepth research tools and investor commentary for Evgen Pharma (EVG) and other London Stock Exchange equities.
Evgen Pharma Share Price Chart
Register now for FREE Evgen Pharma share price charts
Evgen Pharma Share Price Information
| Name | Evgen Pharma | Epic | EVG |
|---|---|---|---|
| Sector | n/a | ISIN | GB00BSVYN304 |
| Activites | n/a | Index | n/a |
Evgen Pharma Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 05/04/2024 | BUY | Huw Jones | CEO | 122,293 |
| 05/04/2024 | PLAC | Huw Jones | CEO | 3,000,000 |
| 05/04/2024 | PLAC | Susan Foden | NED | 600,000 |
| 05/04/2024 | PLAC | Toni Hanninen | FD | 1,000,000 |
| 05/03/2021 | PLAC | Richard Moulson | RES | 3,787 |
Evgen Pharma Company News
Holding(s) in Company
RNS Number : 8035G Evgen Pharma PLC 27 November 2020 TR-1: S tandard form for notification of major holdings NOTIFICATION...
Holding(s) in Company
RNS Number : 7566G Evgen Pharma PLC 27 November 2020 TR-1: S tandard form for notification of major holdings NOTIFICATION...
Evgen Pharma recruits first patient in study to assess acute respiratory infections drug
Drug development company Evgen Pharma said it had enrolled and dosed its first patient in the STAR trial evaluating SFX-01 as a treatment for acute respiratory infections. This phase II/III trial would investigate whether the Company's lead asset, SFX-01, 'can reduce the severity, or prevent...
More Evgen Pharma Company News >>
Register now for FREE Evgen Pharma company news
Evgen Pharma Share Price Discussions
EVG Evolving! (EVG)
******************************************************************** Great news released today.. I'm already up 60% from a few weeks ago.. all looking good! dyor etc.. Evgen Pharma gets FDA orphan designation StockMarketWire.com The US Food & Drug Administration has granted Evgen...
Evolve a profit with EVOLUTION (EVG)
HI I'M BACK AND I THINK I MIGHT HAVE FOUND A GEM. WORTH £250 MILLION WITH CLOSE TO £100M IN CASH. AND A PROFIT OF £25 MILLION THIS YEAR. pLUS LOTS OF TOP FINANCIAL BRANDS -THIS MUST BE A BARGAIN? wHAT DO YO THINK? bE QUICK IF YOU'RE A BOTTOM FISHER ITS MOVING OFF IT'S YEAR LOW AS WE...
Evolution Group Continues to Evolve (EVG)
Long term hold for me and rarely trade them - Nice trading update yesterday - I add a few in the dips and look forward to a bull market one day soon - EVG will gain in every way Times - The parent Evolution Group rose 1p to 50½p on an upbeat year-end trading statement. The AIM-listed...
Register now for FREE Evgen Pharma share price discussions